home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 05/25/23

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 25, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, incl...
BPTS - Biophytis has Filed with the EMA for Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 15, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, incl...

BPTS - Organogenesis, Arcturus top healthcare gainers; ImmunityBio, Dynatronics among losers

2023-05-11 10:00:13 ET Gainers: Organogenesis ( ORGO ) +23% . Arcturus Therapeutics ( ARCT ) +14% . Phathom Pharmaceuticals ( PHAT ) +14% . Pulse Biosciences ( PLSE ) +13% . PharmaCyte Biotech ( PMCB ) +11% . Losers: ImmunityBi...

BPTS - Successful Capital Increase for Biophytis with Euro2.3 million Raised

Success of the placement with professional investors, historical supporters of the Company, for an amount of €1.9M. Strong participation of retail investors via the PrimaryBid platform with an offer allocated to €0.4M [1] . Funds raised to finance the Marketing Authorisati...
BPTS - Biophytis Launches a Round of Fundraising for Approximately 2 Million Euros

Capital increases as part of a global offering comprising an offer reserved for professional investors and a public offering for retail investors through the PrimaryBid platform. The PrimaryBid offering will close on May 10 2023 at 10pm Paris time and the offering reserved for professional i...

BPTS - Biophytis seeks EMA meeting to discuss prefiling for oral COVID drug Sarconeos

2023-05-09 06:43:19 ET Biophytis ( NASDAQ: BPTS ) filed a request with the European Medicine Agency (EMA) for a meeting to discuss pre-submission of an application for conditional marketing authorization (cMA) of Sarconeos (BIO101) to treat severe COVID-19 in Europe. The ...

BPTS - Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the Treatment of COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 9, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, inc...
BPTS - TScan, Vivani top healthcare gainers; Community Health, Jin Medical lead losers' pack

2023-05-02 10:02:29 ET Gainers: TScan Therapeutics ( TCRX ) +17% . Vivani Medical ( VANI ) +15% . SI-BONE ( SIBN ) +13% . Kiniksa Pharmaceuticals ( KNSA ) +12% . Harmony Biosciences ( HRMY ) +8% . Losers: Community Health ...

BPTS - Biophytis Strengthens its Management Team

Appointment of Chiara Baccelli as Director of Pharmaceutical Operations and Quality Assurance Appointment of Nicolas Fellmann as Chief Financial Officer PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWORE / May 2, 2023 / Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the "Compan...

BPTS - Biophytis (BPTS) Investor Presentation - Slideshow

2023-04-21 11:15:24 ET The following slide deck was published by Biophytis S.A. in conjunction with this event. For further details see: Biophytis (BPTS) Investor Presentation - Slideshow
Previous 10 Next 10